Bromide

Bromide

SCHEMBL18604193

NCCCCCCCCCCCc1cc[n+](CCS)cc1.[Br-]

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ CHKA known ✓ P35790 1/20 0.37
▸ HRH1 P35367 4/20 0.47
▸ MAOA P21397 1/20 0.47
▸ HTR2A P28223 1/20 0.39
▸ CHRNA7 P36544 3/20 0.37
▸ CHRNA10 Q9GZZ6 3/20 0.37
▸ CHRNA9 Q9UGM1 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL18604235 1.00 HRH1 (0.47) HRH1MAOAHTR2ACHRNA7CHRNA10
Bromide SCHEMBL18604120 1.00 HRH1 (0.47) HRH1MAOAHTR2ACHRNA7CHRNA10
Bromide SCHEMBL18604177 1.00 HRH1 (0.47) HRH1MAOAHTR2ACHRNA7CHRNA10
Bromide SCHEMBL18604255 1.00 HRH1 (0.47) HRH1MAOAHTR2ACHRNA7CHRNA10
Bromide SCHEMBL18604244 1.00 HRH1 (0.47) HRH1MAOAHTR2ACHRNA7CHRNA10
Bromide SCHEMBL18604231 1.00 HRH1 (0.47) HRH1MAOAHTR2ACHRNA7CHRNA10
Bromide SCHEMBL18604024 0.98 MAOA (0.48) HRH1MAOAHTR2ACHRNA7CHRNA10
Bromide SCHEMBL18604221 0.93 MAOA (0.41) HRH1MAOAHTR2ACHRNA7CHRNA10
Bromide SCHEMBL18604097 0.85 TAAR1 (0.45) HTR2ACHKA
Bromide SCHEMBL19741470 0.80 KMT2A (0.46) HTR2ACHKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025070397-A1 ETHYLENE GLYCOL, POLYESTER, POLYESTER PELLETS, MOLDED ARTICLE, FILM, FIBERS, FIBER ARTICLE, MOLDED ARTICLE, PREFORM, POLYESTER FILM, LAMINATED FILM, LAMINATE, AND PACKAGE 大日本印刷株式会社 2025-04-03 — — WO disclosed
US-10550488-B2 Reduction catalyst, reduction reactor and reduction method KABUSHIKI KAISHA TOSHIBA (JP) 2020-02-04 — — US disclosed
US-10465303-B2 Producing system of reduction product KABUSHIKI KAISHA TOSHIBA (JP) 2019-11-05 — — US disclosed
US-10308574-B2 Reduction catalyst and chemical reactor KABUSHIKI KAISHA TOSHIBA (JP) 2019-06-04 — — US disclosed
US-20180073154-A1 REDUCTION CATALYST, REDUCTION REACTOR AND REDUCTION METHOD KABUSHIKI KAISHA TOSHIBA (JP) 2018-03-15 — — US disclosed
EP-3293288-A1 REDUCTION CATALYST, REDUCTION REACTOR AND REDUCTION METHOD Kabushiki Kaisha Toshiba (JP) 2018-03-14 — — EP disclosed
US-20170369405-A1 REDUCTION CATALYST AND CHEMICAL REACTOR KABUSHIKI KAISHA TOSHIBA (JP) 2017-12-28 — — US disclosed
US-20170073827-A1 PRODUCING SYSTEM OF REDUCTION PRODUCT KABUSHIKI KAISHA TOSHIBA (JP) 2017-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10308574-B2 Reduction catalyst and chemical reactor MPO, NOX4, IDH2 CHKA 3577/4885HRH1 4532/4885MAOA 255/4885
US-20170369405-A1 REDUCTION CATALYST AND CHEMICAL REACTOR MPO, NOX4, IDH2 CHKA 3577/4885HRH1 4532/4885MAOA 255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback